ARRHYTHMOGENIC CARDIOMYOPATHY
Clinical trials for ARRHYTHMOGENIC CARDIOMYOPATHY explained in plain language.
Never miss a new study
Get alerted when new ARRHYTHMOGENIC CARDIOMYOPATHY trials appear
Sign up with your email to follow new studies for ARRHYTHMOGENIC CARDIOMYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a targeted pill tame dangerous heart rhythms in genetic heart disease?
Disease control Recruiting nowThis study tests an experimental drug called tideglusib in people with a genetic heart condition that causes dangerous heart rhythms. The goal is to see if the drug can reduce the number of extra heartbeats and prevent serious rhythm events. About 120 adults with a confirmed gene…
Matched conditions: ARRHYTHMOGENIC CARDIOMYOPATHY
Phase: PHASE2 • Sponsor: Hamilton Health Sciences Corporation • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Heart MRI study aims to simplify diagnosis for millions
Knowledge-focused Recruiting nowThis study will use advanced MRI scans to measure heart tissue in 2000 people with different heart conditions, like heart attacks and cardiomyopathies. The goal is to create a reference guide for doctors to interpret these scans and see if a simpler method without contrast dye wo…
Matched conditions: ARRHYTHMOGENIC CARDIOMYOPATHY
Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 07:04 UTC